Table of Contents:
1 Introduction	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	12
1.2.1 Overview of Market Research Methodology	12
1.2.2 Market Assumption	13
1.2.3 Secondary Data	13
1.2.4 Primary Data	13
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	20
2.1 Market Size and Forecast	20
2.1.1 Impact of COVID-19 on World Economy	21
2.1.2 Impact of COVID-19 on the Market	25
2.2 Major Growth Drivers	27
2.3 Market Restraints and Challenges	33
2.4 Emerging Opportunities and Market Trends	36
2.5 Porter’s Fiver Forces Analysis	40
3 Segmentation of North America Market by Offering	44
3.1 Market Overview by Offering	44
3.2 Instruments	46
3.3 Test Kits & Consumables	48
3.3.1 Kits & Assays	49
3.3.2 Consumables	51
3.4 Software & Services	53
4 Segmentation of North America Market by Transplant	55
4.1 Market Overview by Transplant	55
4.2 Solid Organ Transplant	57
4.2.1 Kidney	59
4.2.2 Liver	60
4.2.3 Heart	61
4.2.4 Lung	62
4.2.5 Pancreas	63
4.2.6 Kidney-Pancreas	64
4.2.7 Other Solid Organ Transplants	65
4.3 Stem Cell Transplant	66
4.4 Soft Tissue Transplant	67
5 Segmentation of North America Market by Application	68
5.1 Market Overview by Application	68
5.2 Diagnostics	70
5.2.1 Donor Testing	71
5.2.2 Recipient Testing	72
5.3 Translational Research	73
6 Segmentation of North America Market by Technology	74
6.1 Market Overview by Technology	74
6.2 Molecular Technologies	76
6.2.1 PCR	78
6.2.2 Sequencing	79
6.2.3 Other Molecular Technologies	80
6.3 Serology	81
6.4 Flow Cytometry	82
6.5 Other Technologies	83
7 Segmentation of North America Market by End User	84
7.1 Market Overview by End User	84
7.2 Hospitals and Transplant Centers	86
7.3 Reference Laboratories	87
7.4 Academic and Research Institutions	88
7.5 Other End Users	89
8 North America Market 2021-2031 by Country	90
8.1 Overview of North America Market	90
8.2 U.S.	93
8.3 Canada	96
8.4 Mexico	98
9 Competitive Landscape	100
9.1 Overview of Key Vendors	100
9.2 New Product Launch, Partnership, Investment, and M&A	103
9.3 Company Profiles	104
Abbott Laboratories Inc.	104
ARUP Laboratories	106
BAG Health Care GmbH	107
Becton Dickinson and Company	108
bioMérieux S.A.	109
Bio-Rad Laboratories, Inc.	110
CareDx, Inc.	111
Eurofins Scientific	112
F. Hoffmann-La Roche Ltd.	113
Illumina, Inc.	114
Immucor, Inc.	115
Laboratory Corporation of America Holdings	116
Novacyt Group	117
Omixon Ltd.	118
OPKO Health	119
QIAGEN N.V.	120
Quest Diagnostics Incorporated	121
Thermo Fisher Scientific Inc.	122
RELATED REPORTS	123

List of Tables:

Table 1.  Snapshot of North America Organ Transplant Diagnostics Market in Balanced Perspective, 2021-2031	18
Table 2. World Economic Outlook, 2021-2031	22
Table 3. World Economic Outlook, 2021-2023	23
Table 4. World Health Spending by Region, $ bn, 2013-2020	32
Table 5.  Main Product Trends and Market Opportunities in North America Organ Transplant Diagnostics Market	36
Table 6. North America Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	44
Table 7. Main Platforms and Key Vendors	47
Table 8. North America Organ Transplant Diagnostics Market: Test Kits & Consumables by Type, 2021-2031, $ mn	48
Table 9. Main Kits & Assays and Key Vendors	50
Table 10. Main Consumables and Key Vendors	52
Table 11. Main Services and Key Vendors	54
Table 12. North America Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	55
Table 13. North America Organ Transplant Diagnostics Market: Solid Organ Transplant by Type, 2021-2031, $ mn	58
Table 14. North America Organ Transplant Diagnostics Market by Application, 2021-2031, $ mn	68
Table 15. North America Organ Transplant Diagnostics Market: Diagnostics by Type, 2021-2031, $ mn	70
Table 16. North America Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	74
Table 17. North America Organ Transplant Diagnostics Market: Molecular Technologies by Type, 2021-2031, $ mn	77
Table 18. North America Organ Transplant Diagnostics Market by End User, 2021-2031, $ mn	84
Table 19. North America Organ Transplant Diagnostics Market by Country, 2021-2031, $ mn	91
Table 20. U.S. Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	95
Table 21. U.S. Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	95
Table 22. U.S. Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	95
Table 23. Canada Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	97
Table 24. Canada Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	97
Table 25. Canada Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	97
Table 26. Mexico Organ Transplant Diagnostics Market by Offering, 2021-2031, $ mn	99
Table 27. Mexico Organ Transplant Diagnostics Market by Transplant, 2021-2031, $ mn	99
Table 28. Mexico Organ Transplant Diagnostics Market by Technology, 2021-2031, $ mn	99
Table 29. Abbott Laboratories Inc.: Company Snapshot	104
Table 30. Abbott Laboratories Inc.: Business Segmentation	105
Table 31. Abbott Laboratories Inc.: Product Portfolio	105

List of Figures:

Figure 1. Research Method Flow Chart	12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031	17
Figure 4. North America Organ Transplant Diagnostics Market, 2021-2031, $ mn	20
Figure 5. Impact of COVID-19 on Business	25
Figure 6. Primary Drivers and Impact Factors of North America Organ Transplant Diagnostics Market	27
Figure 7.  Leading Causes of Death in the World, 2019-2020, million	30
Figure 8.  Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million	31
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060	31
Figure 10. Primary Restraints and Impact Factors of North America Organ Transplant Diagnostics Market	33
Figure 11. Investment Opportunity Analysis	37
Figure 12. Porter’s Fiver Forces Analysis of North America Organ Transplant Diagnostics Market	40
Figure 13. Breakdown of North America Organ Transplant Diagnostics Market by Offering, 2021-2031, % of Revenue	45
Figure 14. North America Addressable Market Cap in 2022-2031 by Offering, Value ($ mn) and Share (%)	45
Figure 15. North America Organ Transplant Diagnostics Market by Offering: Instruments, 2021-2031, $ mn	46
Figure 16. North America Organ Transplant Diagnostics Market by Offering: Test Kits & Consumables, 2021-2031, $ mn	48
Figure 17. North America Organ Transplant Diagnostics Market by Test Kits & Consumables: Kits & Assays, 2021-2031, $ mn	49
Figure 18. North America Organ Transplant Diagnostics Market by Test Kits & Consumables: Consumables, 2021-2031, $ mn	51
Figure 19. North America Organ Transplant Diagnostics Market by Offering: Software & Services, 2021-2031, $ mn	53
Figure 20. Breakdown of North America Organ Transplant Diagnostics Market by Transplant, 2021-2031, % of Sales Revenue	56
Figure 21. North America Addressable Market Cap in 2022-2031 by Transplant, Value ($ mn) and Share (%)	56
Figure 22. North America Organ Transplant Diagnostics Market by Transplant: Solid Organ Transplant, 2021-2031, $ mn	57
Figure 23. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Kidney, 2021-2031, $ mn	59
Figure 24. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Liver, 2021-2031, $ mn	60
Figure 25. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Heart, 2021-2031, $ mn	61
Figure 26. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Lung, 2021-2031, $ mn	62
Figure 27. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Pancreas, 2021-2031, $ mn	63
Figure 28. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Kidney-Pancreas, 2021-2031, $ mn	64
Figure 29. North America Organ Transplant Diagnostics Market by Solid Organ Transplant: Other Solid Organ Transplants, 2021-2031, $ mn	65
Figure 30. North America Organ Transplant Diagnostics Market by Transplant: Stem Cell Transplant, 2021-2031, $ mn	66
Figure 31. North America Organ Transplant Diagnostics Market by Transplant: Soft Tissue Transplant, 2021-2031, $ mn	67
Figure 32. Breakdown of North America Organ Transplant Diagnostics Market by Application, 2021-2031, % of Sales Revenue	69
Figure 33. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)	69
Figure 34. North America Organ Transplant Diagnostics Market by Application: Diagnostics, 2021-2031, $ mn	70
Figure 35. North America Organ Transplant Diagnostics Market by Diagnostics: Donor Testing, 2021-2031, $ mn	71
Figure 36. North America Organ Transplant Diagnostics Market by Diagnostics: Recipient Testing, 2021-2031, $ mn	72
Figure 37. North America Organ Transplant Diagnostics Market by Application: Translational Research, 2021-2031, $ mn	73
Figure 38. Breakdown of North America Organ Transplant Diagnostics Market by Technology, 2021-2031, % of Revenue	75
Figure 39. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)	75
Figure 40. North America Organ Transplant Diagnostics Market by Technology: Molecular Technologies, 2021-2031, $ mn	76
Figure 41. North America Organ Transplant Diagnostics Market by Molecular Technologies: PCR, 2021-2031, $ mn	78
Figure 42. North America Organ Transplant Diagnostics Market by Molecular Technologies: Sequencing, 2021-2031, $ mn	79
Figure 43. North America Organ Transplant Diagnostics Market by Molecular Technologies: Other Molecular Technologies, 2021-2031, $ mn	80
Figure 44. North America Organ Transplant Diagnostics Market by Technology: Serology, 2021-2031, $ mn	81
Figure 45. North America Organ Transplant Diagnostics Market by Technology: Flow Cytometry, 2021-2031, $ mn	82
Figure 46. North America Organ Transplant Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn	83
Figure 47. Breakdown of North America Organ Transplant Diagnostics Market by End User, 2021-2031, % of Revenue	85
Figure 48. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)	85
Figure 49. North America Organ Transplant Diagnostics Market by End User: Hospitals and Transplant Centers, 2021-2031, $ mn	86
Figure 50. North America Organ Transplant Diagnostics Market by End User: Reference Laboratories, 2021-2031, $ mn	87
Figure 51. North America Organ Transplant Diagnostics Market by End User: Academic and Research Institutions, 2021-2031, $ mn	88
Figure 52. North America Organ Transplant Diagnostics Market by End User: Other End Users, 2021-2031, $ mn	89
Figure 53. Breakdown of North America Organ Transplant Diagnostics Market by Country, 2021 and 2031, % of Revenue	91
Figure 54. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)	92
Figure 55. U.S. Organ Transplant Diagnostics Market, 2021-2031, $ mn	94
Figure 56. Canada Organ Transplant Diagnostics Market, 2021-2031, $ mn	96
Figure 57.  Organ Transplant Diagnostics Market in Mexico, 2021-2031, $ mn	98
Figure 58. Growth Stage of North America Organ Transplant Diagnostics Industry over the Forecast Period	100

Selected Key Players: 
Abbott Laboratories Inc.
ARUP Laboratories
BAG Health Care GmbH
Becton Dickinson and Company
bioMérieux S.A.
Bio-Rad Laboratories, Inc.
CareDx, Inc.
Eurofins Scientific
F. Hoffmann-La Roche Ltd.
Illumina, Inc.
Immucor, Inc.
Laboratory Corporation of America Holdings
Novacyt Group
Omixon Ltd.
OPKO Health
QIAGEN N.V.
Quest Diagnostics Incorporated
Thermo Fisher Scientific Inc. 
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)